Air Pollution Raises Risk of Type 2 Diabetes, Says Landmark Indian Study

The FDA Must Decide Whether Crispr’s Gene-Editing Promise Is Worth the Risk

Apple warns Indian journalists, opposition politicians of hacking attempts

Egyptian healthtech Almouneer raises $3.6M to scale its platform for treating diabetes and obesity